Strategies to Increase the Value of Colon Cancer MedicationsByMarj P. Zimmerman, MS, BSPharm, RPh,Stanton R. MehrDecember 6th 2012
Breast Cancer: Will Treatment Costs Outpace Effectiveness?ByMarj P. Zimmerman, MS, BSPharm, RPh,Stanton R. MehrDecember 6th 2012
The Keys to Obtaining Best Value in Non-Small Cell Lung CancerByMarj P. Zimmerman, MS, BSPharm, RPh,Stanton R. MehrSeptember 18th 2012
Myeloproliferative Disorders and MyelofibrosisByMarjorie P. Zimmerman, MS, BSPharm, RPh,Stanton R. MehrMay 24th 2012
Targeted Products Yield Most Promising ResultsByJennifer Klem, PhD,Stanton R. Mehr,Marj Pestil Zimmerman, BSPharmMarch 12th 2012A New Era in Targeted Treatment Has Begun
